Barbiturates Test Evidence
Has Caused a False Positive
Ethosuximide
Both sources San-José et al., Clin Chem Lab Med 2018 Saitman et al., J Anal Toxicol 2026
What It Found
- A patient taking ethosuximide had an unexpected barbiturate screen.
- The investigators also reproduced the reaction with added ethosuximide.
Keep in Mind
- It does not establish how often a person taking ethosuximide will screen positive.
Source San-José et al., Clin Chem Lab Med 2018
Keep in Mind
- The study involved one device.
Test Studied
- Drug-Screen-Multi 10TD urine strip
Ibuprofen
Source Rollins et al., Clin Chem 1990
What It Found
- One sample from a person taking ibuprofen gave a false-positive barbiturate result in a prospective study of 510 specimens across three NSAIDs.
Keep in Mind
- Events were uncommon and the exact method matters.
- These observations do not establish a routine effect of NSAIDs.
Test Studied
- Older barbiturate fluorescence polarization immunoassay (1990)
Naproxen
Source Rollins et al., Clin Chem 1990
What It Found
- One sample from a person taking naproxen gave a false-positive barbiturate result in a prospective study of 510 specimens across three NSAIDs.
Keep in Mind
- Events were uncommon and the exact method matters.
- These observations do not establish a routine effect of NSAIDs.
Test Studied
- Older barbiturate fluorescence polarization immunoassay (1990)
Glutethimide
Source Roerig et al., Clin Chem 1975
What It Found
- Researchers comparing urine testing methods reported a false-positive barbiturate result from glutethimide on the radioimmunoassay.
Keep in Mind
- The study dates to 1975.
- Its abstract gives no glutethimide threshold and does not address modern urine screens.
Test Studied
- Historical barbiturate radioimmunoassay evaluated in human urine
Source Allen and Stiles, Clin Toxicol 1981
What It Found
- Allen and Stiles independently confirmed a glutethimide reaction in pooled drug-free human urine.
Keep in Mind
- The 1981 assay predates current reagents.
Test Studied
- Historical Syva EMIT DAU barbiturate assay
Both sources Roerig et al., Clin Chem 1975 Allen and Stiles, Clin Toxicol 1981
Keep in Mind
- This does not establish a rate at therapeutic doses.
Aminoglutethimide
Both sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The study’s supplementary comparison lists aminoglutethimide as a weak barbiturate cross-reactant on Abbott AxSYM and Biosite Triage at 100 micrograms/mL.
Keep in Mind
- This is an assay comparison drawing on manufacturer data.
- Patient-level evidence and applicability to current local tests were not established.
Test Studied
- Historical Abbott AxSYM and Biosite Triage
The Test Is Made to Find It
Butalbital
Source Fritch et al., Ther Drug Monit 2011
What It Found
- Participants given butalbital, itself a barbiturate, excreted the drug in urine.
Test Studied
- Clinical urine GC-MS after a single oral dose
Source FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
What It Found
- The Quidel urine screening panel also detects it in analytical testing.
Test Studied
- Quidel Triage barbiturate assay
Both sources Fritch et al., Ther Drug Monit 2011 FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
Keep in Mind
- A prescription can explain genuine barbiturate detection.
- The result alone does not establish dose or impairment.
Phenobarbital
Source Fritch et al., Ther Drug Monit 2011
What It Found
- Participants given phenobarbital, itself a barbiturate, excreted the drug in urine.
Test Studied
- Clinical urine GC-MS after a single oral dose
Source FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
What It Found
- The Quidel urine screening panel also detects it in analytical testing.
Test Studied
- Quidel Triage barbiturate assay
Both sources Fritch et al., Ther Drug Monit 2011 FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
Keep in Mind
- A prescription can explain genuine barbiturate detection.
- The result alone does not establish dose or impairment.
Primidone
Source Kauffman et al., Clin Pharmacol Ther 1977
What It Found
- Children receiving long-term primidone excreted phenobarbital, an active metabolite.
- A drug test that identifies phenobarbital can therefore reflect prescribed primidone.
Keep in Mind
- This is genuine production of a barbiturate.
- A confirmed metabolite by itself does not establish that phenobarbital was taken separately.
Test Studied
- Urinary phenobarbital following primidone metabolism
Secobarbital
Source Fritch et al., Ther Drug Monit 2011
What It Found
- Participants given secobarbital, itself a barbiturate, excreted the drug in urine.
Test Studied
- Clinical urine GC-MS after a single oral dose
Source FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
What It Found
- The Quidel urine screening panel also detects it in analytical testing.
Test Studied
- Quidel Triage barbiturate assay
Both sources Fritch et al., Ther Drug Monit 2011 FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical…, 2019
Keep in Mind
- A prescription can explain genuine barbiturate detection.
- The result alone does not establish dose or impairment.
Amobarbital
Source Wilson et al., Ann Clin Biochem 1994
What It Found
- Secobarbital-directed reagents were less sensitive to amobarbital, a genuine barbiturate used in the UK.
Keep in Mind
- A weak class response can result in missed exposure.
- The abstract does not give individual kit cutoffs.
Test Studied
- UK external quality assessment of secobarbital-directed immunoassays
Suspected, but Not Proven
Tolmetin
Source Joseph et al., J Anal Toxicol 1995
What It Found
- The older EMIT evaluation documented optical interference across assays.
- It did not establish that tolmetin made a urine barbiturate screen read positive.
Keep in Mind
- The mechanism and direction matter.
- An instrument error or depressed signal is not evidence of a false-positive screen.
- A separate high-concentration TDx benzodiazepine finding is indexed under benzodiazepines.
Tests Studied
- Older Syva EMIT on Hitachi 704
- Compared with Abbott TDx
Mephenytoin
Source Buchwald, J Toxicol Clin Toxicol 2000
What It Found
- The authors of a mephenytoin overdose report raise possible urine barbiturate positivity.
Keep in Mind
- The abstract does not document the patient's barbiturate result, confirmation or assay.
- Valproic acid was also ingested.
Test Studied
- Urine toxicology screen, reagent unstated
Phenytoin
Source Siff and Finkler, Clin Chem 1988
What It Found
- A 1988 letter names phenytoin and a hydroxylated metabolite in a false-positive urine barbiturate result.
Keep in Mind
- The indexed letter has no abstract.
- The assay and its applicability to currently used urine immunoassays need verification.
Tests Studied
- Historical urine barbiturate method
- Reagent not verified
Tested: No False Positive Found
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Dextromethorphan
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Diphenhydramine
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels